ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software
May 18, 2021 16:05 ET | Source: ClearPoint Neuro, Inc. ClearPoint Neuro, Inc. Irvine, California, UNITED STATES
SOLANA BEACH, Calif., May 18, 2021 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling company providing navigation and delivery to the brain, today announced the first human cases of the SmartFrame Array Neuro Navigation System and Software. The ‘Array’ system is designed to streamline workflows and reduce procedure time in both the MRI Suite and in the Operating Room. The Company believes the added flexibility of a potential Operating Room placement will allow more hospital sites and surgeons to access ClearPoint’s technology and clinical support.
Copy shortlink:
The cities of Minneapolis and St. Paul, along with several businesses, will keep mask requirements in place even though Gov. Tim Walz signed an executive order Friday ending the statewide mask mandate.
For the near future at least, Minnesotans are likely to face a patchwork of different rules about mask-wearing, making the face covering still an essential item to carry in cars, pockets, purses or backpacks when needed to gain entry beyond the Masks are required sign.
At a time when case growth, test positivity rates and hospitalization rates have been decreasing but remain above cautionary levels set by state health officials, the removal of mask mandates could set the stage for more infections in those places where masks are few and far between.
Senescent immune cells cause inflammation and tissue damage all over the body and shorten lifespan. Therefore, they should be targeted with senolytics.
other viruses and basically insert the code into the mRNA construct. This is new technology that will make it more direct, more straightforward to design vaccines for other infectious diseases and tumors, Schacker said.
Schacker says he already knows of groups using this method to work on a vaccine for HIV. I think that s probably where a lot of the focus will go and I think influenza is another target that people are working on, he said.
Schacker says there are two big advantages to mRNA vaccines. First, they seem to trigger a better immune response, which likely makes them more effective. Second, they re made more efficiently.
Erenumab monotherapy active long term in patients with episodic migraine Disclosures: Novartis Pharma AG supported the study. Goadsby reports receiving grants from Amgen, Eli Lilly and Company and Celgene; personal fees from numerous pharmaceutical companies; and a patent for headache assigned to eNeura without fee. Please see the study for all other authors’ relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published.